A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/1998
12/16/1998	EP0883627A1 Radionuclide labeling of vitamin b12 and coenzymes thereof
12/16/1998	EP0883344A1 Therapeutic molecules generated by trans-splicing
12/16/1998	EP0699191B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/16/1998	EP0687253B1 4-aminopyridines, process for preparing the same and medicaments containing the same
12/16/1998	EP0672686B1 Ganglioside gm3 derivative having fluorinated ceramide moiety
12/16/1998	EP0454781B1 Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
12/16/1998	CN1202173A Amine derivatives of epipodophyllotoxin 2',3'-dideoxyglycosides, preparation method therefor and use thereof as drug and for treating cancer
12/16/1998	CN1202166A Hydrolysis-promoting taxane hydrophobic derivatives
12/16/1998	CN1202154A Aromatic carboxylic acid esters, production of same and use of same as medicaments
12/16/1998	CN1201673A Wolfberry powder and production thereof
12/16/1998	CN1201666A Capsule of cartilage powder of shart and preparation thereof
12/16/1998	CN1041204C Pentacyclic triterpenoid compound as toposomerase inhibitors or cell differentiation inducers
12/16/1998	CN1041201C Vitamin D3-analogies, their preparation, their medical compositions and usages
12/15/1998	US5849923 Heterocyclic-substituted naphthalenyl retinobenzoic acid derivatives
12/15/1998	US5849903 Antisense oligonucleotides for IL-8 and IL-8 receptor
12/15/1998	US5849899 Human tumor suppressor
12/15/1998	US5849877 Antigen-binding sites of antibody molecules specific for cancer antigens
12/15/1998	US5849796 Ortho-substituted benzoil acid derivatives
12/15/1998	US5849794 Guanylhydrazones and their use to treat inflammatory conditions
12/15/1998	US5849777 Cell differentiation induction with mevalonate and mevalonolactone derivatives
12/15/1998	US5849748 Therapeutic quassinoid preparations with antineoplastic antiviral, and herbistatic activity
12/15/1998	US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists
12/15/1998	US5849710 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
12/15/1998	US5849709 Saccharopeptides and derivatives thereof
12/15/1998	US5849692 Cyclic peptides containing Arg-Gly-Asp, and derivatives thereof, as adhesion inhibitors
12/15/1998	US5849691 Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II
12/15/1998	US5849586 Infective protein delivery system
12/15/1998	US5849580 Nucleic acid encoding a NF-κB activation regulatory protein, IκBβ
12/15/1998	US5849556 Human growth-related CDC10 homolog
12/15/1998	US5849535 Human growth hormone variants
12/15/1998	US5849509 Nuclear matrix proteins
12/15/1998	US5849482 Crosslinking oligonucleotides
12/15/1998	US5849283 Human interleukin-6 receptor antagonists
12/15/1998	US5849261 Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
12/15/1998	CA1340245C Monoclonal antibody for differentiation of squamous cell carcinoma antigens and method of use for same
12/15/1998	CA1340244C Dnas and processes for their preparation, novel plasmids comprising themnovel polypeptides and processes for their preparation and novel anti-tumor agents comprising said polypeptides
12/15/1998	CA1340215C Cc-1065 analogs having two cpi subunits
12/15/1998	CA1340184C Cloning and characterizing omega-interferon and related genes
12/11/1998	CA2233584A1 7tm receptor hlwar77
12/11/1998	CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998	WO1998055638A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
12/10/1998	WO1998055622A1 Preparation of glycosylated tumor necrosis factor
12/10/1998	WO1998055615A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3
12/10/1998	WO1998055607A2 Tumor targeted vector
12/10/1998	WO1998055598A1 A METHOD OF INHIBITING CANCER CELL GROWTH USING A VECTOR EXPRESSING pRb2/p130
12/10/1998	WO1998055510A2 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
12/10/1998	WO1998055505A1 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
12/10/1998	WO1998055493A1 Natural antitumor or antiviral substances and use of the same
12/10/1998	WO1998055491A1 Process for preparing etoposide
12/10/1998	WO1998055483A1 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
12/10/1998	WO1998055479A1 Antagonists of gonadotropin releasing hormone
12/10/1998	WO1998055472A1 Coumarin derivatives, methods of preparation and application as medicines
12/10/1998	WO1998055470A1 Antagonists of gonadotropin releasing hormone
12/10/1998	WO1998055468A1 Oxazole compounds useful as pge2 agonists and antagonists
12/10/1998	WO1998055463A1 Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents
12/10/1998	WO1998055449A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties
12/10/1998	WO1998055150A1 Txu-7-pap immunotoxin and use thereof
12/10/1998	WO1998055123A1 Antagonists of gonadotropin releasing hormone
12/10/1998	WO1998055119A1 Antagonists of gonadotropin releasing hormone
12/10/1998	WO1998055116A1 Antagonists of gonadotropin releasing hormone
12/10/1998	WO1998055112A1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds
12/10/1998	WO1998055103A1 Anti-tumoral therapy agent
12/10/1998	WO1998054963A2 207 human secreted proteins
12/10/1998	WO1998039465A3 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
12/10/1998	WO1998039429A3 Compositions for treatment of disorders involving programmed cell death
12/10/1998	WO1998033893A3 Ribozymes cleaving epidermal growth factor receptors
12/10/1998	DE19724796A1 Mittel zur Antitumortherapie Means for antitumor therapy
12/10/1998	CA2292881A1 Antagonists of gonadotropin releasing hormone
12/10/1998	CA2292880A1 Antagonists of gonadotropin releasing hormone
12/10/1998	CA2292760A1 Vector
12/10/1998	CA2292699A1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds
12/10/1998	CA2292643A1 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
12/10/1998	CA2292605A1 Antagonists of gonadotropin releasing hormone
12/10/1998	CA2292426A1 Txu-7-pap immunotoxin and use thereof
12/10/1998	CA2291829A1 Antagonists of gonadotropin releasing hormone
12/10/1998	CA2291647A1 Antagonists of gonadotropin releasing hormone
12/10/1998	CA2291260A1 207 human secreted proteins
12/10/1998	CA2289564A1 Preparation of glycosylated tumor necrosis factor
12/10/1998	CA2288898A1 Process for preparing etoposide
12/10/1998	CA2234411A1 Novel compounds
12/09/1998	EP0882794A2 Human complementarity determining region (CDR)-grafted antibody to ganglioside gm2
12/09/1998	EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998	EP0882791A2 WNT-11 polypeptides
12/09/1998	EP0882737A1 Ligated d-protein and method of indentifying compounds that modulate receptor activity
12/09/1998	EP0882736A1 LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
12/09/1998	EP0882723A1 Thioxanthenone antitumor agents
12/09/1998	EP0882134A1 Methods and compositions for protective and therapeutic genetic immunization
12/09/1998	EP0882130A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
12/09/1998	EP0882040A1 Antagonists of gonadotropin releasing hormone
12/09/1998	EP0882031A1 Novel benzoyl guanidine derivatives, process for their preparation and their use in the preparation of medicines
12/09/1998	EP0881914A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression
12/09/1998	EP0881913A1 Liposomal-viral dna complexes for treating disease
12/09/1998	EP0881910A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
12/09/1998	EP0881906A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants
12/09/1998	EP0810866A4 Use of acid-sensitive organo- transition metal compounds in cancer treatment
12/09/1998	EP0776338B1 Immunoconjugates comprising tyrosine kinase inhibitors
12/09/1998	EP0719251B1 Bicyclo (2.2.2) octane derivatives cholecystokinin and/or gastrin antagonists
12/09/1998	EP0712390B1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
12/09/1998	EP0422186B1 Use of oncostatin m for suppressing mhc antigens
12/09/1998	CN1201458A (-) cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy) phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate

1 ... 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 ... 2211